No Kings' Protests Sweep US as Demonstrators Challenge Trump Policies

Afghanistan, March 29 -- Thousands of Americans rallied nationwide on Saturday, denouncing Donald Trump's policies, expanding presidential power, immigration crackdowns and the war with Iran. Thousan... Read More

Palm Sunday: The Day Hope Demanded More Than Celebration

Nigeria, March 29 -- Palm Sunday is not just a date on the calendar. It is a scene, a tension, a beginning that carries its ending within it. The streets of Jerusalem are alive with expectation. The a... Read More

Pastor arrested for allegedly raping, impregnating 16-year-old girl

Nigeria, March 29 -- A pastor in Anambra State has been detained at the State Criminal Investigation Department (SCID) of the police for allegedly raping and impregnating a 16-year-old girl in the sta... Read More

Tripura: 173 candidates in fray for multi-cornered TTAADC polls

India, March 29 -- The upcoming elections to the Tripura Tribal Areas Autonomous District Council (TTAADC) are poised for a multi-cornered contest, with all major political parties fielding candidates... Read More

Manipur CM lauds plan to convert Imphal's solid waste into natural gas

India, March 29 -- Solid waste management in Manipur, particularly in Imphal, faces severe challenges, with current systems relying on conventional collection and disposal methods. Efforts are now un... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and... Read More

• ««
• «
• 5129
• 5130
• 5131
• 5132
• 5133
• 5134
• 5135
• 5136
• 5137
• 5138
• »
• »»